Columbia Labs ticks up revenue; Chiltern rebrands after M&A;

> Columbia Laboratories ($CBRX) boosted its quarterly revenue by 61%, bringing in $11.5 million as it transitions into a hybrid business model. More

> Chiltern has rebranded itself after a series of restructuring moves, and the CRO now employs more than 2,200 workers in 45 countries, covering all phases of drug development. News